204,760 Shares in CeriBell (NASDAQ:CBLL) Bought by Next Century Growth Investors LLC

Next Century Growth Investors LLC bought a new stake in shares of CeriBell (NASDAQ:CBLL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 204,760 shares of the company's stock, valued at approximately $5,299,000. Next Century Growth Investors LLC owned approximately 0.57% of CeriBell as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC acquired a new position in shares of CeriBell in the 4th quarter worth approximately $128,120,000. Vanguard Group Inc. acquired a new position in CeriBell in the fourth quarter worth approximately $18,015,000. Franklin Resources Inc. bought a new position in shares of CeriBell in the fourth quarter valued at $12,460,000. Massachusetts Financial Services Co. MA acquired a new stake in shares of CeriBell during the 4th quarter valued at $10,750,000. Finally, Federated Hermes Inc. bought a new stake in shares of CeriBell during the 4th quarter worth $9,634,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. LADENBURG THALM/SH SH initiated coverage on shares of CeriBell in a report on Friday, April 4th. They set a "buy" rating and a $32.00 price target on the stock. Canaccord Genuity Group restated a "buy" rating and set a $33.00 price target on shares of CeriBell in a report on Wednesday, February 26th. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, CeriBell presently has an average rating of "Buy" and an average target price of $32.50.

CeriBell Price Performance

NASDAQ:CBLL traded up $0.43 during trading hours on Thursday, hitting $14.92. 425,076 shares of the company traded hands, compared to its average volume of 267,305. CeriBell has a twelve month low of $10.01 and a twelve month high of $32.75. The stock's 50-day moving average price is $20.58.

CeriBell (NASDAQ:CBLL - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.08). The firm had revenue of $18.53 million for the quarter, compared to the consensus estimate of $17.55 million. As a group, equities research analysts anticipate that CeriBell will post -2.46 EPS for the current year.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.